Trial Profile
Phase I trial of ChronVac-C [hepatitis C DNA vaccine] in combination with TG-4040 in treatment-naive patients with hepatitis C.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2011
Price :
$35
*
At a glance
- Drugs Hepatitis C DNA vaccine (Primary) ; TG 4040 (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 10 Oct 2011 Planned initiation date changed to 1 December 2011, according to Inovio media release.
- 20 Apr 2011 New trial record